Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ Microcytic anemias (MCV < 80 mcm3) Iron deficiency Thalassemia Anemia of inflammation/chronic disease (more often normocytic) Sideroblastic anemia (congenital, lead exposure, medications)—rare Copper deficiency or zinc poisoning—rare Macrocytic anemias (MCV > 100 mcm3) Megaloblastic anemias (due to abnormalities in DNA synthesis; hypersegmented neutrophils also occur) Vitamin B12 deficiency Folate deficiency Antimetabolite drugs, such as methotrexate or zidovudine Nonmegaloblastic anemias (no hypersegmented neutrophils) Alcohol abuse Liver disease Hypothyroidism Myelodysplastic syndrome (often causes pancytopenia) Normocytic anemias Anemia of inflammation/chronic disease (chronic kidney disease, infection, inflammation, malignancy, aging) Early iron deficiency Bone marrow suppression Invasion by malignancy or granulomas Acquired pure red cell aplasia (parvovirus B19, HIV, medications [mycophenolate mofetil, trimethoprim-sulfamethoxazole, phenytoin, recombinant human erythropoietins], thymoma, other malignancies, immune disorders) Aplastic anemia (often causes pancytopenia) Endocrine (hypopituitarism or hypothyroidism) Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Download the Access App: iOS | Android Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.